Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, PCT to Co-Develop, Market Invitrogen’s Media and Cell-Separation Technologies

NEW YORK (GenomeWeb News) — Invitrogen and Progenitor Cell Therapy today said they will co-develop and -market Invitrogen’s media and cell separation technologies, PCT said today.
The agreement will include marketing, co-referrals, joint proposals, and technical consulting around Invitrogen’s Dynabeads and Dynabeads ClinExVivo, which are ex vivo T-cell and immune-functioning technologies.
PCT specializes in cell manufacturing and consulting services that include “regulatory, financial, technical process and quality systems strategies,” the company said.
Invitrogen’s Dynal Bead Based Separation Group Director Oystein Amellem said PCT’s experience with Dynabeads and with “various expansion and media culture systems” is valuable to Invitrogen for “ongoing product development, product testing and validation, as well as customized technical integration and implementation of services. … ” 
PCT’s development and manufacturing model “will be critical to the successful commercialization of many cell therapy products,” Amellem added.
PCT Chief Technology Officer Stewart Craig said partnerships with companies offering popular platforms such as Invitrogen’s are important to PCT’s strategy to offer integrated products for development because it positions the company to better help its customers develop and market their cell-based products.
Financial terms of the agreement were not released.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.